Immediate Impact
19 standout
Citing Papers
Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder
2023 Standout
Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system
2023 Standout
Works of Sandra Thiel being referenced
Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations
2020
Interferon-beta exposure during first trimester is safe in women with multiple sclerosis—A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sandra Thiel | 270 | 339 | 383 | 42 | 530 | |
| P. Chandra | 98 | 117 | 145 | 34 | 498 | |
| Frank G. Keller | 233 | 34 | 243 | 65 | 555 | |
| Sam Milliken | 70 | 115 | 213 | 31 | 565 | |
| Apostolos Pourtsidis | 246 | 71 | 57 | 42 | 630 | |
| P Royer | 128 | 274 | 42 | 36 | 596 | |
| Jessica Hochberg | 117 | 187 | 171 | 42 | 530 | |
| Katarzyna Derwich | 217 | 34 | 41 | 65 | 520 | |
| Roar Sandvei | 182 | 55 | 81 | 37 | 586 | |
| Guenter Henze | 206 | 53 | 118 | 34 | 506 | |
| Daniel Satgé | 201 | 57 | 55 | 43 | 547 |
All Works
Login with ORCID to disown or claim papers
Loading papers...